Dimension: Access and Patient Flow (A+PF)

Rationale for measurement

International studies have demonstrated extended length of stay within overcrowded EDs leads to poorer clinical outcomes for patients.

Measurement methodology and data sources

  • data extract from hospital site patient administration system (PAS), extrapolated by HSE Business Intelligence Unit, measuring for all ED attendances the length of time spent in the Emergency Department.


Average time spent in ED – non admitted / admitted

Target

  • 100% of patients admitted / discharged from ED within 24 hours

Performance

Beaumont Hospital

  • average time spent in ED for admitted patients is 15.3 hours for reporting month 2022
  • average time spent in ED for non-admitted patients is 8.05 hours for reporting month 2022

Cavan General Hospital

  • average time spent in ED for admitted patients is 8.02 hours for reporting month 2022
  • average time spent in ED for non-admitted patients is 4.26 hours for reporting month 2022

Connolly Hospital

  • average time spent in ED for admitted patients is 11.59 hours for reporting month 2022
  • average time spent in ED for non-admitted patients is 5.69 hours for reporting month 2022

Drogheda Hospital

  • average time spent in ED for admitted patients is 11.51 hours for reporting month 2022
  • average time spent in ED for non-admitted patients is 6.56 hours for reporting month 2022

Target

  • 85% patients admitted or discharged or non-admitted from ED within 9 hours of registration (NSP 2022)

Performance

Beaumont Hospital

  • October 2022 64.7% compliance with 9 hour non-admitted PET / 17.9% compliance with admitted PET

Cavan General Hospital

  • October 2022 89.9% compliance with 9 hour non admitted PET / 59.9% compliance with admitted PET

Connolly Hospital

  • October 2022 84.1% compliance with 9 hour non admitted PET / 33.8% compliance with admitted PET

Drogheda Hospital

  • October 2022 76.4% compliance with 9 hour non admitted PET / 49.4% compliance with admitted PET

RCSI Hospital Group

  • October 2022 77.2% compliance with 9 hour non admitted PET / 39.6% compliance with admitted PET

National Performance Comparator

  • October 2022 78.8% compliance with 9 hour non admitted PET / 46.9% compliance with admitted PET

Target:    

  • 97% of patients wait less than 24 hours in Emergency Department for ward bed accommodation (NSP 2022)

Performance


  • Beaumont Hospital – Oct 2022 3.8% >24hours (0.5% Oct 2021) performance deterioration demonstrated
  • Cavan Hospital – Oct 2022 0.7% >24hours (2.3% Oct 2021) performance improvement demonstrated
  • Connolly Hospital – Oct 2022 0.1% >24 hours (0.1% Oct 2021) performance maintenance demonstrated
  • Drogheda Hospital – Oct 2022 3.0% >24hours (1.2% Oct 2021) performance deterioration demonstrated

  • RCSI HG – Oct 2022 2.4% > 24hours (0.9% Oct 2021)
  • National – Oct 2022 5,1% > 24hours (3.6% Oct 2021)

Rationale for measurement

Overcrowding within ED negatively impacts on both dignity and privacy for patients and the ability of staff to deliver fully effective care / treatment. Related international studies have also demonstrated extended length of stay within overcrowded EDs leads to poorer clinical outcomes for concerned patients.

Measurement methodology and data sources

  • data refers to the daily number of patients on trolleys in ED, at 8.00am daily, as recorded by the hospital
  • data set is provided by BIU – HSE

Target

The following daily targets were set by the HSE Acute Hospital Division:

  • Beaumont Hospital: 12
  • Cavan General Hospital: 8
  • Connolly Hospital: 8
  • Drogheda Hospital: 12
  • RCSI Hospital Group: 40
  • National: 228

Performance

Beaumont Hospital

  • increase from n=0 to n=2 in average number of patients awaiting ward bed accommodation in ED 2022 / 2021 for October (total count increase from n=0 Jan-Oct 2021 to n=702 Jan-Oct 2022)
    • performance improvement commenced in July 2016 generally maintained during 2020 reporting period
    • an average daily count value of 2 demonstrated for October 2022 (Target <12 achieved)

Cavan General Hospital

  • decrease from n=5 to n=4 in average number of patients awaiting ward bed accommodation in ED 2022 / 2021 for October (total count increase 62% (n=481) from n=775 Jan-Oct 2021 to n=1,256 Jan-Oct 2022)
  • an average daily count of 4 demonstrated for October 2022 (Target <8 achieved)

Connolly Hospital

  • performance maintenance of n=<0 in average number of patients awaiting ward bed accommodation in ED 2022 / 2021 for October (total count increase from n=0 Jan-Oct 2021 to n=280 Jan-Oct 2022)
  • an average daily count of 0 demonstrated for October 2022 (Target <8 achieved)

Drogheda Hospital

  • increase from n=3 to n=4 in average number of patients awaiting ward bed accommodation in ED 2022 / 2021 for October (total count increase 120% (n=664) from n=552 Jan-Oct 2021 to n=1,216 Jan-Oct 2022)
  • an average daily count of 4 demonstrated for October 2022 (Target <12 achieved)

RCSI Hospital Group

  • increase from n=8 to n=11 in average number of patients awaiting ward bed accommodation in ED 2022 / 2021 for October (total count increase 160% (n=2,127) from n=1,327 Jan-Oct 2021 to n=3,454 Jan-Oct 2022)
  • an average daily count of 11 demonstrated for October 2022 (Target <40 achieved)

National Performance Comparator

  • increase from n=253 to n=368 in average number of patients awaiting ward bed accommodation in ED 2022 / 2021 for October (total count increase 85% (n=36,295) from n=42,510 Jan-Oct 2021 to n=78,805 Jan-Oct 2022*)
  • an average daily count of 368 demonstrated for October 2022 (Target <228 not achieved)
  • *May and June 2021 national performance not available via TrolleyGAR due to cyber attack therefore YTD 2022 adjusted to reflect same dates for comparative purposes. For reference, actual national YTD 2022 Jan-Jul n=93,904

Rationale for measurement

Significant delay in accessing hospital services delays diagnosis and any necessary treatment commencement with potential for less than optimal outcome for patients.

Measurement methodology and data source

  • Compliance % with waiting time target. Periodic local data extracts submitted to NTPF extrapolated for analysis and publication.

Target

  • 100% patients waiting <12 months for new outpatient appointment (RCSI Hospital Group target)
  • 98% patients waiting <18 months for new outpatient appointment (NSP 2022)

Performance <12 months

Beaumont Hospital

  • 98.1% of patients waiting <12 months on OPD wait list (2022)

Cavan General Hospital

  • 93.3% of patients waiting <12 months on OPD wait list (2022)

Connolly Hospital

  • 95.3% of patients waiting <12 months on OPD wait list (2022)

Drogheda Hospital

  • 87.4% of patients waiting <12 months on OPD wait list (2022)

Louth County Hospital

  • 86.0% of patients waiting <12 months on OPD wait list (2022)

Rotunda Hospital

  • 100% of patients waiting <12 months on OPD wait list (2022)

RCSI Hospital Group – % of OPD Patients <12 months – as at October 2022

  • overall 94.2% of patients waiting <12 months on OPD wait list (2022) in RCSI Hospital Group

National Hospital Groups – % of OPD Patients <12 months – as at October 2022

  • nationally 70.3% of patients waiting <12 months on OPD wait list (2022)
  • st (2022)

Rationale for measurement

Significant delay in accessing hospital services delays diagnosis and any necessary treatment commencement with potential for less than optimal outcome.

Measurement methodology and data source

Number of adult patients waiting for elective inpatient admission/day case. Periodic local data submission to NTFP extrapolated for analysis and publications excluding patients with ‘to come in date‘ (tci) (NTPF – definition).

Target

  • 100% patients waiting <9 months for elective IP/DC (RCSI Hospital Group target)
  • 98% patients waiting <12 months for elective IP/DC (NSP 2022)

Performance

Beaumont Hospital

  • 79.6% of patients waiting <9 months for elective IP/DC (2022)

Cavan General Hospital

  • 98.8% of patients waiting <9 months for elective IP/DC (2022)

Connolly Hospital

  • 94.8% of patients waiting <9 months for elective IP/DC (2022)

Drogheda Hospital

  • 94.0% of patients waiting <9 months for elective IP/DC (2022)

Louth County Hospital

  • 2% of patients waiting <9 months for elective IP/DC (2022). Ophthalmology excluded which comprises 9.8% DC activity and is under the control of IEHG

RCSI Hospital Group

  • 85.2% of patients waiting <9 months for elective IP/DC (2022)

National Hospital Groups – % of IPDC Patients <9 months – as at October 2022

  • nationally 76.2% of patients waiting <9 months for elective IP/DC (2022)

National Hospital Groups – % of IPDC Patients <12 months – as at October 2022

  • nationally 82.5% of patients waiting <12 months for elective IP/DC (2022)

Introduction

Beaumont Hospital is one of 8 Breast Cancer Centres nationally. Each cancer centre provides data to the National Cancer Control Programme (NCCP) on performance against the targets outlined beneath.

Rationale for measurement

Significant delays in accessing hospital services and delays in commencing necessary treatment have the potential for less than optimal patient outcomes.

Measurement methodology and data source

  • periodic local data extracts submitted to the National Cancer Control Programme (NCCP), extrapolated for analysis and publication

Target

  • 95% of attendances whose referral was triaged as urgent by the cancer centre and attended or were offered an appointment within 2 weeks
  • 90% of breast cancer patients triaged as urgent are discussed at MDM within 10 working days of attendance at first OPD
  • 90% of patients with primary invasive or in situ breast tumours are offered surgery within 20 working days of MDM
  • 90% of primary breast cancer patients commenced radiation therapy within 84 days of their final therapeutic surgical procedure
  • 80% of primary breast cancer patients commenced radiation therapy within 28 days of completing chemotherapy

Performance

Beaumont Hospital

  • Beaumont Hospital exceeded National Target set for 2022 reporting period (98.7% achieved against a target of 95%). National performance for October 2022 (78.0%) did not achieve target.

  • 89.1% compliant Q2 2022
  • national performance not published

Patients with primary invasive or insitu breast tumours offered surgery within 20 working days of MDM - Chart

  • 80.7% compliant Q2 2022
  • national performance not published

Primary breast cancer patients who commenced radiation therapy within 84 days of final therapeutic surgical procedure - Chart

  • 90.4% compliant Q2 2022
  • national performance not published

Primary breast cancer patients who commenced radiation therapy within 84 days of final therapeutic surgical procedure - Chart

  • 94.7% compliant Q2 2022
  • national performance not published

Rationale for measurement

Significant delay in accessing hospital services delays diagnosis and any necessary treatment commencement with potential for less than optimal outcome.

Measurement methodology and data source

  • periodic local data extracts submitted to NCCP, extrapolated for analysis and publication

Target:

  • 95% of patients attending the rapid access clinic who attended or were offered an appointment within 10 working days of receipt of referral in the cancer centre
  • in 90% of patients receipt of referral to treatment MDM was ≤ 20 working days
  • in 90% of patients receipt of referral to surgery date offered was ≤ 45 working days

Performance

Beaumont Hospital

  • Beaumont Hospital achieved National Target set for 2022 reporting period (100% against a target of 95%).National performance for October 2022 (94.1%) did not achieve target.

Rapid Access Lung Cancer Clinic - Receipt of referral to treatment MDM < 20 working days - Chart

  • 47.0% compliant Q2 2022
  • national performance not published

Rapid Access Lung Cancer Clinic - Receipt of referral to surgery date offered < 45 working days (surgery not performed in Beaumont Hospital) - Chart

  • 17.0% compliant Q2 2022
  • national performance not published
  • surgery performed in St James’s Hospital

Rationale for measurement

Significant delay in accessing hospital services delays diagnosis and any necessary treatment commencement with potential for less than optimal outcome.

Measurement methodology and data source

  • periodic local data extracts submitted to NCCP, extrapolated for analysis and publication

Target:

  • 95% of patients attending the rapid access clinic who attended or were offered an appointment within 20 working days of receipt of referral in the cancer centre
  • 95% of patients diagnosed with prostate cancer are discussed at the MDM prior to first intervention
  • 80% of histology reports following a first biopsy are available within 10 working days of the procedure

Performance

Beaumont Hospital

  • Beaumont Hospital exceeded National Target set for 2022 reporting period (100% achieved against a target of 95%). National Performance for October 2022 (87.2%) did not achieve target.

Percentage of patients diagnosed with prostate cancer discussed at MDM prior to first intervention - Chart

  • 96.7% compliant Q2 2022
  • national performance not published
  • note1 – therapeutic intervention includes radiotherapy, surgery and active surveillance and excludes hormone treatment

Percentage of histology reports following a biopsy within 10 working days of the procedure

  • 93.8% compliant Q2 2022
  • national performance not published

Introduction

Melanoma also known as malignant melanoma is one of the most common skin cancers. Melanoma is a disease in which malignant (cancer) cells form in melanocytes (cells that colour the skin). The number of people diagnosed with melanoma is increasing rapidly each year in Ireland and around the world1. There are four centres providing melanoma services in the RCSI Hospital Group, Beaumont, Cavan, Connolly and Drogheda Hospitals.

Rationale for measurement

Significant delays in accessing hospital services and delays in diagnosis have the potential for less than optimal patient outcomes. The Key Performance Indicators (KPIs) outlined beneath measure access to treatment, multidisciplinary discussion and pathology reporting

Measurement methodology and data source

Periodic local data extracts, extrapolated for analysis and publication.

Target

  • 95% of patients referred for excision of melanoma in situ or primary invasive cutaneous malignant melanoma are seen within 6 weeks of referral
  • 95% of patients with a diagnosis of melanoma in situ or primary invasive cutaneous malignant melanoma should be discussed at MDM within 4 weeks
  • 90% of patient histopathology reports of melanoma in situ or primary invasive cutaneous malignant melanoma which have primary excision should be issued within 10 working days of biopsy

PerformanceMelanoma – Access, MDM Discussion And Pathology - Chart

  • Beaumont Hospital provide MDM for all RCSI hospitals and some external hospitals
  • Beaumont and Drogheda Hospitals provide shared melanoma services
  • N/A refers to patients discussed at MDM in Beaumont hospital

Reference: 1 https://www.mariekeating.ie/cancer-information/skincancer/melanoma

Rationale for measurement

Significant delay in accessing hospital services delays diagnosis and any necessary treatment commencement with potential for less than optimal outcome for patients.

Measurement methodology and data source

  • Periodic local data extracts submitted to NTPF, extrapolated for analysis and publication

Target

  • 100% of patients identified a requiring urgent colonoscopy undertaken / offered appointment within 28 days

Performance

RCSI Hospital Group

  • 100% compliance within the RCSI Hospital Group for October 2022 monthly reporting period

National Performance

  • 98.1% compliance nationally for October 2022 monthly reporting period. n=2,648 total patient volume nationally requiring urgent colonoscopy at end of Oct-22 (5% decrease vs same period in 2021).

Rationale for measurement

Significant delay in accessing hospital services delays diagnosis and any necessary treatment commencement with potential for less than optimal outcome.

Measurement methodology and data sources

  • Periodic local data extracts submitted to NTPF, extrapolated for analysis and publication

Target

  • 65% of patients identified as requiring routine GI endoscopy undertaken or offered appointment within 13 weeks (NSP 2022)

Performance

Beaumont Hospital

  • Beaumont Hospital is currently achieving this target for monthly reporting period (63.8% compliance)

Cavan General Hospital

  • Cavan General Hospital is currently achieving this target for monthly reporting period (74.6% compliance)

Connolly Hospital

  • Connolly Hospital is currently achieving this target for monthly reporting period (53.9% compliance)

Drogheda Hospital

  • Drogheda Hospital is currently achieving this target for monthly reporting period (88.0% compliance)

Louth County Hospital

  • Louth County Hospital is currently achieving this target for monthly reporting period (85.6% compliance)

RCSI Hospital Group

  • RCSI Hospital Group is currently achieving this target for monthly reporting period (68.4% compliance)

National Performance Comparator

  • nationally this target is not being met for monthly reporting period (57.2% compliance)

Rationale for measurement

Significant delay in accessing hospital services delays diagnosis and any necessary treatment commencement with potential for less than optimal outcome.

Measurement methodology and data sources

  • Monthly data provided by BowelScreen programme

Target

  • Minimum standard target is ≥90% of clients offered a colonoscopy appointment that occurs within 20 working days from when a client was deemed clinically suitable following pre-assessment / notification of positive FIT

Performance

RCSI Hospital Group

  • Connolly achieved 100% compliance Oct-22.

  • LCH achieved 100% compliance Oct-22.

  • national performance for Oct-2022 79.4% did not achieve compliance target

Introduction

A cervical screening test (previously known as a smear test) looks to see if a woman might be at greater risk of developing cervical cancer in the future. Occasionally following smear test abnormal cells may be identified and a further test called a colposcopy may be required. A colposcopy is a simple examination that is carried out in the same way as a smear test. A doctor or nurse will look at the cervix (neck of the womb) using a type of microscope called a colposcope. During the examination, a liquid or dye may be applied to the cervix to help identify any changes to the cells and to decide if any treatment is needed

Rationale for measurement

There are two centres providing colposcopy services in the RCSI Hospital Group, Louth County Hospital and the Rotunda Hospital.

Delays have the potential to result in less than optimal outcomes for patients.

Measurement methodology and data sources

  • % of patients referred to the Colposcopy Service who were offered an appointment
  • periodic local data extracts submitted to Cervical Screening Service, extrapolated for analysis and publication

Target

  • Urgent Referral – 90% seen within 2 weeks of referral
  • High Grade Referral – 90% seen within 4 weeks of referral
  • Low Grade Referral – 90% seen within 8 weeks of referral

Performance

Colposcopy Services - Chart

  • national data not produced in a manner that enables comparison

Urgent Referrals - Seen within 2 weeks of Referral - Chart

  • LCH exceeded target for Q3 2022 (100% achieved against a target of 90%) for urgent referrals seen within 2 weeks of referral
  • Rotunda did not achieve target for Q3 2022 (76% achieved against a target of 90%) for urgent referrals seen within 2 weeks of referral

High Grade Referrals - Seen within 4 weeks of Referral - Chart

  • LCH exceeded target for Q3 2022 (94% achieved against a target of 90%) for high grade referrals seen within 4 weeks of referral
  • Rotunda did not achieve target for Q3 2022 (69% achieved against a target of 90%) for high grade referrals seen within 4 weeks of referral

Low Grade Referrals - Seen within 8 weeks of Referral - Chart

  • LCH exceeded target for Q3 2022 (100% achieved against a target of 90%) for low grade referrals seen within 8 weeks of referral
  • Rotunda did not achieve target for Q3 2022 (12% achieved against a target of 90%) for low grade referrals seen within 8 weeks of referral

Introduction

Menopause is a natural biological process and is diagnosed after a woman has had 12 months without a menstrual period. Vaginal bleeding after menopause is abnormal and all postmenopausal vaginal bleeding should be investigated. The cause of postmenopausal bleeding (PMB) may be entirely harmless. However, 5- 10% of women who present with PMB will have endometrial cancer1.

Rationale for measurement

5%-10% of women who present with PMB will have endometrial cancer1. Delays in diagnosis have the potential to result in less than optimal outcomes for patients. In August 2020, the National Women and Infants Health Programme (NWIHP) recommended that all referrals of women with PMB from GPs should be assessed in a hospital Outpatient/Ambulatory Clinic within 4 weeks2. National KPIs developed by NWIHP measure the numbers of patients who receive histological confirmation within 8 or 12 weeks.

Gynaecology Services in the RCSI Hospital Group are provided in Beaumont Hospital, Cavan Monaghan Hospitals, Connolly Hospital, Louth Hospitals, and the Rotunda Hospital.

Measurement methodology and data sources

  • Number of patients referred to the Gynaecology Service with post-menopausal bleeding (PMB)
  • KPI 1 – Number of patients referred to the Gynaecology Service with PMB seen within 4 weeks (also expressed as percent)
  • KPI 2 – Number of patients referred to the Gynaecology Service with PMB who required biopsy and had histological confirmation within 8 weeks of referral from GP (also expressed as percent)
  • KPI 3 – Number of patients referred to the Gynaecology Service with PMB who required biopsy and had histological confirmation within 12 weeks of referral from GP (also expressed as percent)

Local hospital data extrapolated quarterly for analysis and publication

Target

  • 100% of patients seen within 4 weeks of referral
  • 100% of patients have histological confirmation within 12 weeks of referral

Performance

Q2-22 Data

KP1 - Postmenopausal Bleeding (PMB) - Chart

  • Beaumont, Cavan, Drogheda and the Rotunda Hospitals did not achieve the target of 100% for KPI 1

  • Beaumont, Cavan and Drogheda Hospitals did not achieve the target of 100% for KPI 2

  • Beaumont, Cavan and Drogheda Hospitals did not achieve the target of 100% for KPI 3
  • *note all Connolly patients with PMB who required a biopsy received histological confirmation within 8 weeks

References

1. Gredmark T, Kvint S, Havel G, Mattson L. Histopathological findings in women with postmenopausal bleeding. BJOG 1995; 102:133-136.

2. NWIHP corresponded August 2020: National Clinical Guidance on the appropriate timeframe for the investigation of Postmenopausal Bleeding

Rationale for measurement

Beaumont Hospital is the National Referral Centre for Neurosurgery in Ireland. Neurosurgery concerns the operative and non-operative management of patients with disorders of the central and peripheral nervous systems. The specialty developed initially through the treatment of cranial trauma and intracranial mass lesions. Subsequent advances in microsurgical techniques, non-invasive imaging, neuro-anaesthesia, intensive care, image-guided surgery, and the introduction of sophisticated radio-oncological and interventional treatments have substantially enhanced and widened the scope of effective neurosurgical treatment. Delay in access to Unit can result in delay in treatment commencing with potential for less than optimal outcome for patients.

Measurement methodology and data sources

  • Beaumont is the National Neurosurgical Unit. Therefore data for Beaumont hospital only is represented.
  • Periodic local data extracts submitted quarterly and retrospectively extrapolated for analysis and publication.

 Targets

  1. 100% of patients triaged as a Traumatic Brain Injury (TBI) admitted to Unit within 12 hours of acceptance.
  2. 90% of patients triaged as Grade I / II aneurysmal Subarachnoid Haemorrhage (aSAH) admitted to Unit within 24 hours of acceptance.
  3. 90% of patients triaged as having a Space Occupying Lesion (SOL) are transferred to Unit within 5 working days / 7 calendar days of acceptance.

Performance

RCSI Hospital GroupPatients triaged as a Traumatic Brain Injury (TBI) admitted to Unit within 12hrs of acceptance

  • 100% (38 out of 38 patients) were admitted within the specified time for Q3 2022. KPI achieved.

% of Patients with Traumatic Brain Injury admitted to Unit within 12hrs - Chart

  • 96% (23 out of 24 patients) were admitted within the specified time for Q3 2022. KPI achieved.

% of Patients with Sub-arachnoid Haemorrhage admitted to Unit within 24hrs of acceptance - Chart

  • 83% (95 out of 115 patients) were admitted within the specified time for Q3 2022. KPI not achieved.

Rationale for measurement

Significant delay in securing necessary diagnostic image report can delay primary diagnosis, treatment commencement or treatment review with potential for less than optimal outcome for patients.

Measurement methodology and data sources

  • waiting time from diagnostic order identification and diagnostic being undertaken (either GP or Consultant)
  • local site data sets extrapolated for analysis and publication, by definition excluding time staged diagnostic order requirements
  • national data set currently combines CT, MRI and US patient cohorts segregates into urgent, semi urgent, routine, excludes these patients not vetted using ‘new’ criteria or not vetted electronically – accordingly actual national performance for their specific diagnostics is not readily discernible or comparable

Target

  • Ultrasound – 100% compliance < 3 months (RCSI HG target)
  • MRI – 100% compliance < 6 months (RCSI HG target)
  • CT – 100% compliance < 6 months (RCSI HG target)

Performance

Beaumont Hospital

  • US 82.0% waiting < 3 months – Beaumont did not achieve target
  • MRI 96.0% waiting < 6 months – Beaumont did not achieve target
  • CT 99.5% waiting < 6 months – Beaumont did not achieve target

Connolly Hospital


  • US 100% waiting < 3 months – Connolly achieved target
  • MRI 100% waiting < 6 months – Connolly achieved target
  • CT 100% waiting < 6 months – Connolly achieved target

Cavan Hospital

  • US 100% waiting < 3 months – Cavan achieved target
  • MRI 100% waiting < 6 months – Cavan achieved target
  • CT 100% waiting < 6 months – Cavan achieved target

Drogheda Hospital

  • US 72.8% waiting < 3 months – Drogheda/LCH did not achieve target
  • MRI 98.4% waiting < 6 months – Drogheda did not achieve target
  • CT 95.1% waiting < 6 months – Drogheda did not achieve target (Drogheda CT includes out-patients scanned in LC

RCSI Hospital Group

  • US 80.7% waiting < 3 months – Group did not achieve target
  • MRI 97.6% waiting < 6 months – Group did not achieve target
  • CT 98.8% waiting < 6 months – Group did not achieve target

Rotunda Hospital (not included in Group total – only Gynae scans)

  • US 35% waiting < 3 months – Rotunda did not achieve target

NB – actual national performance for diagnostics is not readily discernible or comparable

Rationale for measurement

Non-attendance of new patients for OPD appointment negates the ability to diagnose and treat and generally wastes clinical time. This wasted clinical time significantly adds to wait times for other patients.

Measurement methodology and data sources

  • periodic local data extracted and extrapolated for analysis and publication by HSE BIU
  • source for national data provided by BIU OPD MDR

Target

  • <12% of new OPD bookings do not attend scheduled appointment

Performance

RCSI Hospital 

  • cumulative for 2022 reporting period 15.0% (n=22,172) of total new bookings did not attend (DNA) scheduled appointments / 2021 12.9% DNA (n=18,231)
    • Beaumont 2022 20.7% DNA / 2021 17.2% DNA
    • Monaghan 2022 11.8% DNA / 2021 7.6% DNA
    • Cavan 2022 11.4% DNA / 2021 6.7% DNA
    • Drogheda 2022 9.2% DNA / 2021 8.9% DNA
    • Connolly 2022 15.9% DNA / 2021 17.0% DNA
    • – Rotunda 2022 12.4% DNA / 2021 10.5% DNA
    • Louth 2022 12.0% DNA / 2021 8.6% DNA

National Performance Comparator

  • during September 2022 monthly reporting period 13.5% of total new bookings (n=13,409) did not attend scheduled appointment. National performance for October 2022 not available at time of report publication.

Introduction

Elective day surgery is the admission of selected patients to hospital for a planned surgical procedure who return home on the same day. Elective day surgery benefits patients as they receive treatment that is suited to their needs and allows them to recover in their own home. In addition the risk of patients contracting a hospital acquired infection is reduced. Elective day case surgery releases inpatient beds for major cases, this improves throughput of patients and reduces waiting lists.

Rationale for measurement

75% of elective admissions on each of the 24 procedures identified can be carried out as day cases (National Elective Surgery Programme, Royal College of Surgeons in Ireland, Irish College of Anaesthetists and Health Service Executive).

(Orchidopexy, Circumcision, Inguinal Hernia Repair, Excision of Breast Lump, Anal Fissure Dilatation or Excision, Haemorrhoidectomy, Laparoscopic Cholecystectomy, Varicose Vein Stripping or Ligation, Transurethral Resection of Bladder Tumour (<2cm), Excision of Dupuytren’s Contracture, Carpal Tunnel Decompression, Excision of Ganglion, Arthroscopy, Bunion Operations, Removal of Metal-ware, Extraction of Cataract with/without Implant, Correction of Squint, Myringotomy, Tonsillectomy, Sub Mucous Resection, Reduction of Nasal Fracture, Operation for Bat Ears, Dilatation and Curettage/Hysteroscopy, Laparoscopy).

Measurement methodology and data sources

Local Hospital HIPE Data extrapolated for analysis and publication and published on a quarterly basis.

Target

75% of treatments in basket case are carried out as a day case.

Performance RCSI Hospitals Group Basket of 24 - Chart

  • 81% of procedure basket undertaken on a day case basis – overall target achieved
  • national dataset not available

Introduction:

A colonoscopy is an examination of the bowel using a small camera on the end of a thin flexible tube. The tube is inserted into the rectum and then into the large bowel.

During the examination a small sample of the lining of the bowel may be taken to look at more closely. This is called a biopsy. The test looks for any polyps or signs of disease in the lining of the bowel. Polyps are small growths that are not cancer but, if not removed, might turn into cancer over time. If polyps are found they are usually removed during the colonoscopy. This is to reduce the risk of cancer developing.

Rationale for measurement

Internationally accepted guidelines on performance indicators for colonoscopy recommend monitoring of the detection rates of suspicious lesions including polyps and adenomas.

Measurement methodology and data sources

Data is recorded in local hospital Endoscopy Units and uploaded to the National Quality Assurance Intelligence System (NQAIS). NQAIS functions as a central repository for quality improvement data and was developed by the Conjoint Board in Ireland of the Royal College of Physicians and Royal College of Surgeons and HSE Health Intelligence Ireland.

Results are reported as colonoscopies with polyp detected expressed as a % of total colonoscopies per endoscopist.

Data Sources:

  • NQAIS via Local hospital Endoscopy Units

Target

  • ≥ 20% of all colonoscopies should have a polyp(s) detected

Performance

  • all hospitals in RCSI Hospital Group achieved target Q3 2022
  • Q2-21 data unavailable due to cyber attack

Introduction:

Caecal intubation is defined as the passage of the tip of the colonoscope to a point proximal to the ileocecal valve so that the entire cecum is visualised.

Rationale for measurement

Caecal intubation rates (CIR) are a key quality indicator of colonoscopy. Caecal intubation can be expected to be difficult in 5%-15% of colonoscopies, but skilled colonoscopists should be able to apply techniques to overcome the difficulties in most of these instances and reach the cecum in ≥90% of all cases.

Measurement methodology and data sources

Data is recorded in local hospital Endoscopy Units and uploaded to the National Quality Assurance Intelligence System (NQAIS). NQAIS functions as a central repository for quality improvement data and was developed by the Conjoint Board in Ireland of the Royal College of Physicians and Royal College of Surgeons and HSE Health Intelligence Ireland.

Results are reported as number of colonoscopies where the terminal ileum/caecum/anastomosis has been reached as a % of total colonoscopies per endoscopist.

Data Sources:

  • NQAIS via Local hospital Endoscopy Units

Target

  • ≥ 90% of all colonoscopy cases should reach the terminal ileum/caecum/anastomosis

Performance

  • all hospitals in RCSI Hospital Group, with the exception of Connolly Hospital, achieved target Q3 2022
  • Q2-21 data unavailable due to cyber attack

Rationale for measurement

The clinical discharge summary generated at the end of an inpatient stay provides the basis for communication between healthcare professionals in different healthcare settings. In order for the clinical discharge summary to be effective it must be a complete, accurate and relevant record of the inpatient stay and must be sent to the primary care healthcare professional ‘in a timely manner’

National Standard for a Clinical Summary (Patient Discharge) | HIQA

Measurement methodology and data sources

The discharge process requires the transfer of information which involves a clinical discharge summary document being sent from secondary or tertiary care to a patient’s primary healthcare provider. This clinical discharge summary document can be in the form of a letter or the completion of a clinical discharge summary form on paper, or electronically generated, i.e. iPMS or PIPE systems.

Data source local hospital data.

Numerator

Total number of inpatients discharged/month whose primary healthcare provider is sent a clinical discharge summary

Denominator

Total number of inpatient discharges/month

Target

100% of inpatients discharged will have clinical discharge summary issued to their primary healthcare provider within 1 week of discharge.

Performance

Rationale

Datasets contained within discharge correspondence in line with the National Standards for a Clinical Summary (Patient Discharge), HIQA 2013.

Measurement methodology and data sources

In keeping with the HIQA 2013 standard, Clinical Discharge Summaries are audited for completion of the mandatory data set in the following 7 sections:

  1. Patients Details
  2. Primary Healthcare Details
  3. Admission and Discharge Details
  4. Clinical Narrative
  5. Medication Details
  6. Future Management
  7. Details of Persons completing the Discharge Summary

This audit is of electronic patient discharges and data source local hospital data, extrapolated from electronic patient discharge systems:

  • Beaumont PIPE data audit of discharge summaries
  • Cavan iPMS data audit of discharge summaries
  • Connolly iPMS data audit of discharge summaries
  • Drogheda iPMS data audit of discharge summaries

Target

100% of Clinical Discharge Summaries will be completed containing the mandatory data outlined in the 7 specified sections of the HIQA 2013 standard.

Performance

% compliance with mandatory HIQA standards on Clinical Discharge Summary.

  • Beaumont overall compliance rate maintained at 79% in Oct-22 and Sep-22 with 100% compliance in Primary Healthcare Details in Oct-22
  • Cavan overall compliance rate maintained at 95% in Oct-22 and Sep-22, with 100% compliance in Primary Healthcare Details and Admission and Discharge Details in Oct-22
  • Connolly overall compliance rate improved to 95% in Oct-22 from 93% in Sep-22 with 100% compliance in Primary Healthcare Details and Future Management in Oct-22
  • Drogheda overall compliance rate maintained at 78% in Oct-22 and Sep-22
  • RCSI Hospital Group overall compliance rate improved to 87% in Oct-22 from 86% in Sep-22
  • comparative national data not available

Rationale for measurement

Four key reasons that may cause delay in patients receiving timely diagnosis and treatment and can also waste clinical treatment time:

  • tardy recording of patient details onto scheduled care waiting list record (OPD / IP / DC)
  • tardy receipt of booking form in scheduling office and compliance with date stamp received on booking form
  • incomplete patient specific minimum data set record
  • non-compliance with Hospital Group policies in regard to patients not being able to attend (CNA) scheduled OPD appointment / Day Care attendance / Inpatient admission date or patients who do not attend (DNA) scheduled OPD appointment / Day Care attendance / Inpatient admission (see 3.4)

Measurement methodology and data sources

  • periodic sampling (taken on a monthly basis) of Hospital Group ‘waiting list’ data sets to ascertain:
    • time period from receipt of GP referral letter / treatment requirement identification and waiting list record entry
    • advance patient notification in regard to intended scheduled care: OPD appointment / Day Care attendance / Inpatient admission date
    • time period of booking form received in scheduling office and compliance of date stamp received on booking form
    • completeness of patient specific minimum data set record: all hospital waiting list cards examined for inclusion of 25 items
    • for those patients identified as ‘could not attend’ (CNA) i.e. sickness, leave, family commitments review of subsequent practises in terms of record keeping including patient waiting time
    • for those patients identified as ‘did not attend’ (DNA) review of subsequent practices in terms of record keeping including patient waiting time

Target:

  • > 95% of New OPD / Day Care / Inpatient record entries. Two measurements of compliance
    • WL record is updated within 3 working days of receipt of WL booking form
    • start date on WL record = Decision to Admit date
  • 100% compliance with booking form received to scheduling office within one working day
  • 100% compliance with date stamp received on booking form
  • > 95% compliance with sending acknowledgement letter (outpatients)
  • > 85% compliance with completeness of patient specific minimum data set record
  • > 90% compliance with DNA / CNA RCSI HG policies

Performance

% compliance recording of patient details onto scheduled care waiting list record ≤ 3 days

  • note overall sample size n=100 patients (20 per hospital)
  • during October 2022 overall sample group demonstrated 100% compliance with data entry requirements

% compliance of recording of patient details onto scheduled care waiting list record (Start date = DTA)

  • note overall sample size n=100 patients (20 per hospital)
  • during October 2022 overall sample group demonstrated 100% compliance with data entry requirements

% compliance with booking form returned to scheduling office < one working day and date stamped

  • note: overall sample size n=100 patients (20 per hospital)
  • during October 2022 overall sample group demonstrated 82% compliance with booking form returned within 1 working day and date stamped

% compliance of sending acknowledgement letter (Out Patients)

  • note: overall sample size n=100 patients (20 per hospital)
  • during October 2022 overall sample group demonstrated 100% compliance with requirement to send acknowledgement letter

compliance of patient specific minimum data set completeness on WL Record

  • note: overall sample size n=420 data points
  • during October 2022 overall sample group demonstrated 86% compliance with completion of patient specific minimum data set

% compliance of DNA / CNA Policy compliance

  • note: DNA policy: DNA patients are removed from waiting list
  • note: if patient cannot attend (CNA) their wait time clock restarts
  • note: report sample size (DNA n=38; CNA n=41)
  • note: insufficient cancellations/ dnas to comply with 100 records being checked
  • during October 2022 overall sample group demonstrated 100% compliance with DNA and CNA policies
  • national performance not produced